Asylum seekers' perspectives on vaccination and screening policies after their arrival in Greece and The Netherlands by Louka, Christina et al.
  
 University of Groningen
Asylum seekers' perspectives on vaccination and screening policies after their arrival in
Greece and The Netherlands
Louka, Christina; Chandler, Elizabeth; Ranchor, Adelita V; Broer, Hans; Pournaras, Spyros;





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2019
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Louka, C., Chandler, E., Ranchor, A. V., Broer, H., Pournaras, S., Ravensbergen, S. J., & Stienstra, Y.
(2019). Asylum seekers' perspectives on vaccination and screening policies after their arrival in Greece and
The Netherlands. PLoS ONE, 14(12), [e0226948]. https://doi.org/10.1371/journal.pone.0226948
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 21-02-2020
RESEARCH ARTICLE
Asylum seekers’ perspectives on vaccination
and screening policies after their arrival in
Greece and The Netherlands
Christina LoukaID1,2*, Elizabeth Chandler1, Adelita V. Ranchor3, Hans Broer4,
Spyros Pournaras5, Sofanne J. Ravensbergen1,2, Ymkje Stienstra1,2
1 Department of Internal Medicine, University Medical Center Groningen, University of Groningen,
Groningen, Netherlands, 2 ESCMID study group for infections in travelers and migrants, Basel, Switzerland,
3 Department of Health Psychology, University Medical Center Groningen, University of Groningen,
Groningen, Netherlands, 4 Vluchtelingenwerk, Netherlands, 5 Laboratory of Clinical Microbiology,





Europe has been dealing with an increasing number of refugees during the past 5 years.
The timing of screening and vaccination of refugees is debated by many professionals, how-
ever refugees’ perspectives on health issues are infrequently taken into account. In this
study, we aimed to investigate asylum seekers’ perspectives on infectious diseases screen-
ing and vaccination policies.
Materials and methods
Interviews were conducted in Greece and the Netherlands. Asylum seekers and recently
arrived refugees were approached and informed with the help of interpreters; consent forms
were acquired. The survey focused on demographic data, vaccination status, screening pol-
icies and prevention of infectious diseases.
Results
A total of 61 (43 male, 70.5%) refugees (30 Afghanis, 16 Syrian, 7 Erithrean) were interviewed.
Mean age was 35.2 years (SD 13.5) and 50% had received primary or secondary education,
while 24.6% received none. Median time after arrival in Greece and the Netherlands was 24
months (IQR 8.5–28). 44 out of 61 (72.1) participants were willing to be vaccinated after arrival
in Europe, 26 preferred vaccination and screening to be performed at the point of entry. The
need for screening and vaccination was perceived higher amongst participants in Greece
(100% vs 43.3%) due to living conditions leading to increased risk of outbreaks.
Conclusion
Participants were willing to communicate their perspectives and concerns. Screening and
vaccination programs could be more effective when implemented shortly after arrival and
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Introduction
Political turmoil, warfare and instability, specifically in Middle Eastern and African countries,
during the past few years have led to an increase in refugees and asylum seekers entering
Europe. In the Netherlands, 15.410 asylum seekers have arrived between January 2018 and
October 2018 [1]. In Greece, 29.404 refugees have arrived overseas between January 2018 and
November 2018, while the estimated arrivals through mainland are over 12.000 for the same
period. Asylum seekers mostly originate from Syria, Iraq and Afghanistan [2].
Crowded conditions in refugee camps or settlements and the lack of systematic medical
care during their transnational journey, may contribute to the dispersion of infectious diseases
among this vulnerable group. Therefore, vaccinations and infectious diseases screening pro-
grammes in the hosting countries aim to protect public health by preventing dissemination of
infectious diseases [3,4].
A recently published study showed a variety of approaches towards vaccination of both
adult and child migrants across the EU/EEA. In addition, most guidance is not always migrant
specific and the available guidance is frequently not applied in practice [5]. A recent systematic
review documenting the effectiveness of European approaches towards migrant screening
revealed that in European countries migrants are screened mostly in vertical disease programs,
commonly active or latent tuberculosis, or both.
Although recommendations have been made regarding refugees’ vaccination policies, a
WHO report in 2017 revealed that less than a third of countries have migrant specific guide-
lines on immunisation in their national programmes and documented differences in policy,
guidance, and implementation [6]. Moreover, several studies have shown a high prevalence of
micro-organisms expressing antimicriobial resistance (AMR) in the asylum seeker population.
Specifically regarding asylum seekers in the Netherlands, it has been shown that prevalence of
such microbes is higher compared to the general Dutch population [7], supporting AMR
screening at hospital admission.
Furthermore, the optimal timing for implementation of screening and vaccination activities
is frequently debated [8,9]. The stressful and dependent situation for asylum seekers upon
arrival is considered to complicate free decision making by asylum seekers on health issues.
Limited data is available regarding asylum seekers’ perspectives on such policies.
In this study, we aimed to investigate the perspectives of refugees and asylum seekers
regarding screening and vaccination policies in order to obtain helpful information on the
optimal strategy and especially its timing within the migration process. This knowledge could




Interviews were conducted in Greece and in the Netherlands in order to include asylum seek-
ers at different stages of their asylum seeking journey and document possible differences
regarding their perspectives on vaccination and screening policies.
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Greece
Interviews were conducted, between May and June of 2018, at the Structure of Welcoming
and Hosting of Refugees, Schisto, Athens. Refugee camps in Greece are under the authority of
the Greek Ministry of Migration. In order to conduct the study, all necessary forms were sent
to the Ministry and we were granted special permission to access the camp in Schisto. The ref-
ugee camp has been operational since February 2016 and has a capacity of approximately 1000
refugees. The Structure functions under the administrative and financial supervision of the
Ministry of Migration. At the time of the study, 880 refugees were hosted at the camp. Asylum
seekers residing at the structure were approached by our team with the help of an interpreter
at the communal places of the structure.
Netherlands
The interviews were conducted in various locations including the offices of ‘Vluchtelingen-
werk’, a non-governmental organization, between October of 2017 and February of 2018.
Other locations were the tuberculosis center and the department of Internal Medicine of the
UMCG. These departments often provide medical care for asylum seekers. Patients were
approached during admission or during outpatient visits.
Approach and data analysis
Asylum seekers and refugees were approached with the help of an interpreter and the study
was thoroughly explained to the participants. All professional interpreters were officially
trained and certified to communicate and work with asylum seekers. Interviews were con-
ducted in English, Dutch, or any other language with assistance by a professional interpreter
in person or by phone.
Data was anonymously recorded using the Qualtrics survey program. The interviews were
carried out until data saturation was noted independently by two researchers. Data was ana-
lyzed using the statistical software SPSS (SPSS Inc., version 23.0, Chicago, Illinois) and Excel
(Microsoft Excel 2016). Descriptive statistics were used to calculate percentages. Open coding
was used to analyze the qualitative information from the open-ended questions on the
questionnaire.
Throughout the paper Greece and the Netherlands will be referred to as the hosting
countries.
Questionnaire development
A semi structured questionnaire was designed to investigate the perspectives of asylum seekers
with regard to vaccination and screening in the hosting countries. The questionnaire was com-
posed for the purpose of the study under the guidance of an experienced health psychology
researcher (A.V.R.) in University Medical Center Groningen (UMCG), because no standard
questionnaire was available for this topic.
The questionnaire was divided into three main parts; the first part was vaccination oriented,
the second part focused on screening of multidrug-resistant organisms (MDRO) and tubercu-
losis and the third part involved questions regarding infectious diseases screening in general
followed by a brief discussion on this topic. Considering different educational backgrounds of
the participants and the complexity of terms like vaccination and screening, various verbal
approaches by the interpreters were used, in order to simplify the questions. In addition, we
used visual aids, such as photos of medical equipment used in screening and vaccination, i.e.
syringes, swabs and x-rays.
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The estimated duration of the interview was approximately 50 minutes. Prior to the start of
the study, five pilot interviews were conducted. Potential ambiguities were identified and the
questionnaire was revised accordingly. An online tool was used (Qualtrics) during the inter-
views, to enter the data and record the answers. Participants were reminded of the option not
to answer specific questions of the survey in case they did not want to or could not.
Inclusion criteria
Asylum seekers or refugees that arrived in the hosting countries, at least 4 months prior to the
study, were included in the study to allow interviewees to form an opinion based on the experi-
ences in the first months after arrival. In addition, only asylum seekers or refugees who arrived
in the hosting countries after 1/4/2014 were included, so that interviewees would be able to
recollect their experiences with vaccination and screening procedures. Asylum seekers youn-
ger than 18 years old were excluded. Information on children vaccination was obtained by
interviewing their caretakers.
Ethics
In Greece the study was approved by the Hellenic Centre for Disease Prevention and Control
and the Ministry of Migration (protocol number ΚP 15161/2017-02/11/2017, 3/3908/
03.04.2018). In the Netherlands, this study was evaluated by the Ethics committee and was
waived in accordance with Dutch Legislation University Medical Centre Groningen, METc
number non-WMO METc 2017/294. A written informed consent was obtained by all included
participants. All participants were given the option to withdraw from the study at any given
moment without having to give an explanation and were reassured that any potential with-
drawal would have no impact in their health care and asylum status.
Results
General characteristics
Table 1 and Table 2 show the general characteristics of the total of the study group and by
country were the interviews were conducted, respectively. In total, eight asylum seekers
refused to participate, with the main reasons being timing (n = 3), exhaustion because of fast-
ing during Ramadan (n = 2), cultural limitations to talk to a male interpreter without their
spouse present (n = 2), and lack of opinion on the discussed subjects (n = 1).
In total, 61 (former) asylum seekers and recently arrived refugees were included in the
study. 31 of the interviews were conducted in Greece. The majority of participants originated
from Afghanistan and Syria, while nine participants orginated from Sub-Saharan countries.
The most commonly used languages during the interview were Farsi (47.5%), Arabic (16.4%)
and English (14.1%). All interviews in Greece were conducted in person with the assistance of
professional interpreters. In the Netherlands all interviews were conducted in person, 14 of
which without the help of a professional interpreter, in English(n = 8) or in Dutch (n = 6),
while the remaining 16 interviews were conducted with the help of a professional interpreter
over the phone.’
Part A: Vaccination data and perspectives
Vaccinations in adults. 53 out of the 61 participants (86.9%) had been vaccinated in their
country of origin according to the national vaccination schedule. Only 22 out of the 61
(36.1%) participants were asked about their vaccination status by official authorities, health
care workers or NGOs upon arrival in the hosting countries. 12 out of 61 subsequently
Asylum seekers’ perspectives on vaccination and screening policies
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Table 2. General characteristics of the participants that were interviewed by country in which the interviews were
conducted.
Greece (n = 31) Netherlands (n = 30)
Sex (male %) 23 (74.2) 20 (66.6)
Age in years (SD) 34.1 (13.3) 37.2 (14.1)
Number of months in hosting country, median (IQR)) 24 (9–27) 25 (8.5–37.25)
Country of origin (%)
Afghanistan 29 (93.5) 1 (3.3)
Syria 0 16 (53.3)
Eritrea 0 7 (23.3)
Iraq 1 (3.2) 1 (3.3)
Iran 1 (3.2) 0
Others 0 5 (16.7)
Educational level (%)
No education 15 (48.4) 0
Primary education 4 (12.9) 4 (13.3)
Secondary education 7 (22.6) 10 (33.3)
Bachelor’s/master’s 5 (16.1) 16 (53.3)
Profession (%)
Construction worker 8 (25.8) 3 (10.0)
Carpenter 5 (16.1) 0
Seamstress 3 (9.7) 1 (3.3)
Health care worker 1 (3.2) 9 (30.0)
Teacher 2 (6.4) 4 (13.3)
Others 9 (29.0) 13 (43.3)
Asylum granted (%) 11 (35.5) 26 (86.6)
https://doi.org/10.1371/journal.pone.0226948.t002
Table 1. General characteristics of the total of the 61 participants interviewed in both Greece and the
Netherlands.
Number of interviewees (n = 61)
Sex (male %) 43 (70.5)
Age (SD) 35.2 (13.5)
Number of months in hosting country median (IQR)) 24.0 (8.5–28.0)






No education 15 (24.6)
Primary education 8 (13.1)
Secondary education 17 (27.9)
Bachelor’s/master’s 21 (34.4)
Profession (%)
Construction worker 11 (18.0)





Asylum granted (%) 37 (60.7)
https://doi.org/10.1371/journal.pone.0226948.t001
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received additional vaccinations (influenza (n = 2), polio (n = 1), tetanus (n = 1), hepatitis B
(n = 1), unknown (n = 7)). Vaccination was mostly performed by Non-Governmental Organi-
zations (NGO, n = 3) and National Healthcare Employees (n = 4).
Vaccinations in children. 34 out of 61 (55.7%) participants had children under their care
upon arrival in the hosting countries, of which 24 were asked regarding the children’s vaccina-
tion status. 31 out of 34 (91.2%) participants mentioned that the children had been vaccinated
in their country of origin. 27 reported that the children received additional vaccinations in the
hosting countries. The most frequently mentioned vaccinations were MMR (n = 3), DTP
(n = 3), measles (n = 2) and mumps (n = 1). 13 could not recall which vaccines were given to
the children. Children were mainly vaccinated by NGOs (n = 10), public health care facilities
(n = 6), or a doctor at the asylum centre (n = 5).
Perspectives on vaccination. When asked regarding necessity of vaccination, all 31 par-
ticipants interviewed in Greece perceived the need of vaccination as of high importance, while
only 13 out of the 30 participants interviewed in the Netherlands expressed the same opinion.
Point of entry in Europe was considered as the optimal timing for vaccination (n = 26), fol-
lowed by holding level (n = 9). Reasons given regarding the optimal timing for vaccination was
‘to protect ourselves’ (n = 21) and ‘to stop diseases’ (n = 8). According to the opinion of the
participants, it is of no importance by which organization the vaccination is performed, as
long as it is performed (n = 25). Other preferences for the organizations performing vaccina-
tion were the public health care system (n = 11) and NGOs (n = 8).
Willingness and necessity of vaccination. In Greece, all 31 participants were willing to be
vaccinated. In the Netherlands, 13 out of 30 were willing to be vaccinated. In order to have a
better understanding on the perceived importance of vaccination by the participants, we
included a question with specific amounts of money and whether the participants were willing
to pay them in order to be vaccinated. When asked if participants were willing to pay 10,- for
vaccination, 26 out of 31 responded positively in Greece, and 13 out of 30 responded positively
in the Netherlands. When asked if participants were willing to pay 200, 12 out of 31 in Greece
and only 1 out of 30 in the Netherlands responded positively.
55 participants considered increasing the vaccination rate among asylum seekers to be nec-
essary. Explanations given for the wish to increase general vaccination was ‘for protec-
tion’(n = 13), ‘for prevention’ (n = 11), ‘for vulnerable population’ (n = 8) and ‘for overall
health improvement’(n = 6).
Perspectives on promotional work. 55 out of 61 participants considered promotional
work on vaccination useful to increase the vaccination rate among asylum seekers. 29 partici-
pants emphasized the importance of increased educational activities such as seminars/presen-
tations within the hosting facilities, while 8 preferred distribution of written informative
material and 4 preferred outreach programmes.
Part B Screening of infectious diseases
Hospital admissions and screening for MDRO. 13 participants had experienced a hospi-
tal admission in the hosting countries, mostly at the department of pulmonary diseases (n = 5)
and surgery (n = 4). During hospital admission, eight asylum seekers communicated with the
medical staff with the help of professional interpreters.
Screening for MDRO was performed in three participants. One of them was informed
regarding the rationale behind the screening. Nobody had any comments on how the MDRO
screening could be improved.
Screening for tuberculosis and scabies. 24 participants reported to have been screened
for tuberculosis by X-Ray on arrival in the hosting countries. Eight participants were aware of
Asylum seekers’ perspectives on vaccination and screening policies
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the procedure prior to entering the hosting country, of which four were informed by friends
or family members. The remaining four participants were informed by other resources, such
as leaflets distributed in the camps and media. Two participants considered the TB screening
as a negative experience. One of them was experiencing physical pain due to other health prob-
lems during the screening, while the other one reported the experience as negative due to lack
of privacy especially when performed by a medical professional of the opposite sex.
Regarding scabies, 19 reported to have been screened for scabies on arrival in the hosting
countries, mainly in Greece (n = 17). The general experience was described as satisfactory
(n = 18), with the exception of one participant who indicated that not all of his clothes were
returned after they were washed. 17 interviewees considered the screening to be necessary in
order to decrease the burden of scabies. No further comments were made by the interviewees
in order to improve the screening for tuberculosis and scabies.
Part C: Other perspectives on infectious disease screening
53 participants considered screening for infectious diseases useful during the asylum proce-
dure. Main reasons included prevention of infectious diseases among the asylum seeker popu-
lation (n = 14), protection of their own health (n = 11), important for the health of both
asylum seekers and non-asylum seekers population (n = 11), overall health improvement
(n = 8) and the vulnerable aspect of the asylum seekers population (n = 7). Seven participants
opted not to answer this question.
Participants preferred to expand infectious diseases screening policy for asylum seekers in order
to include hepatitis B (n = 34), hepatitis C (n = 31) and HIV (n = 30). The majority of the partici-
pants were particularly concerned regarding sexually transmitted diseases (STDs) and would like
themselves and other asylum seekers to be screened for STDs. Point of entry in Europe was consid-
ered as the optimal timing (n = 42) for such screening, followed by holding level (n = 6) and coun-
try granting asylum (n = 2). Participants expressed concern regarding asylum seekers’ sexual
health even after arrival in the hosting countries. A recurring theme during the interviews was the
conception that different culture and social behavior in the hosting countries could lead to more
liberal sexual behavior and extra marital sex, without the knowledge how to protect one’s health.
When asked to elaborate and further comment on infectious diseases screening and vaccina-
tion implementation, the participants mainly focused on the importance of efficient systematic
medical care (‘good health is above all’, ‘first comes health’) and infectious diseases control (‘need
to protect ourselves and others’), while one of the participants used a rather relevant Afgani prov-
erb, ‘when one sheep is sick then all sheep are sick’. The main complaint expressed was insufficient
medical care and/or understaffed structures (n = 9). Seven suggested that more information on
health care and infectious diseases should be available. Particularly in Greece, four of the partici-
pants expressed concerns regarding scabies outbreaks and skin disorders and emphasized the
burden of disturbing symptoms of such diseases (‘children have a really hard time with the
scratching and pain’). In the Netherlands, participants did not report this scabies burden, possi-
bly as a result of the scabies intervention program [10]. However, one of the participants indi-
cated that not all of his clothes were returned after they were washed and he said that this had
happened to others. Moreover, he had to stay in disposable overalls, while his clothes were being
washed, as part of the intervention program for scabies and louse-borne relapsing fever [11] for
longer than necessary, which he experienced as stigmatizing. 34 had no additional comments.
Discussion
In this study, we aimed to investigate asylum seekers’ perspectives on existing vaccination and
screening policies in Greece and the Netherlands. We interviewed 61 asylum seekers
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originating from various different countries, mainly being Afghanistan and Syria. The majority
of them described not having a negative experience with the screening and vaccination pro-
grammes and considered these policies of great importance for the well-being of asylum seeker
population and public health.
In most European countries, vaccination policies for asylum seekers mainly focus on chil-
dren [5]. However, several studies have shown low vaccination coverage among adult asylum
seekers [12–14]. A Dutch study that included mostly asylum seekers from Syria, Iran, Iraq and
Afghanistan showed insufficient protection against specific preventable diseases. Adults youn-
ger than 25 years showed the lowest measles seroprevalence [15]. In our study, the majority of
participants underlined the defaults regarding adult vaccination and were open to supplemen-
tary vaccination. However, participants in the Netherlands were less supportive of further vac-
cinations. This difference could be explained by the different time points within the asylum
seeking process. Greece functions as one of the transit countries while the Netherlands serves
as a recipient country. Asylum seekers often have to face multiple health checks and experience
different national vaccination policies throughout their journey. By the time they reach their
final destination, their health care priorities may have changed.
Timely implementation of vaccination and screening policies is currently recommended by
WHO and UNHCR [16, 17]. A study from Sweden demonstrated awareness among asylum
seekers regarding the benefits of timely screening, as participants expressed concern over the
health risk posed by their living conditions and potential delay of screening appointment [18].
In accordance, in our study, the majority of the participants preferred screening and vaccina-
tion policies to be implemented at point of entry in Europe. Participants expressed concerns
regarding the increased risk of infectious diseases when people coming from different coun-
tries live closely together in centres and camps.
A systematic review on AMR among migrants in Europe demonstrated high prevalence of
AMR carriage and AMR infection in migrants and concluded that implementing protocols for
the prevention and control of AMR is necessary to ensure migrant health [19]. During the sec-
ond part of the interview, asylum seekers were asked whether they had been admitted to a hos-
pital, and if yes, whether they had been screened for MDROs. In Greece, as expected, none of
the people that were admitted were screened for MDROs since there is no national MDRO
screening policy regarding hospitalized asylum seekers. In the Netherlands, half of the asylum
seekers that were admitted, reported they had been screened.
The majority of asylum seekers and children in need of additional vaccination or medical
care, reported NGOs as the health provider, and such organisations were chosen as the pre-
ferred provider when asked. Political and social debate on which health provider is responsible
for vaccination, screening and general medical care of asylum seekers, in European hosting
countries, have led to an increased involvement of NGOs and volunteers in migrant health.
NGO employees and volunteers do not necessarily have any special training or formal links
with the national health-care system. Thus, linking NGOs with national healthcare systems in
order to avoid discrepancies and optimize referral strategies could be challenging [20].
During the final part of the interview, asylum seekers were asked to give their perspectives
regarding further screening on infectious diseases such as HIV and Hepatitis B and C. The
majority of the participants were particularly concerned regarding STDs. Asylum seekers are
often uneducated or misinformed regarding safe sexual practices and prevention of STDs [21,
22].
The study was conducted in limited refugee camps and structures that we were granted
access to, in Greece and the Netherlands. Subsequently, not all asylum seekers had the same
probability to be included. Furthermore, distribution of demographic characteristics of the
participants depended on the population composition at the time of the study. The number of
Asylum seekers’ perspectives on vaccination and screening policies
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invited participants depended on the documented feedback and interviews were carried out
until data saturation was noted. Access to conduct the interviews in other asylum settings and
in other time periods, may have yielded extra information. Another limitation of the study was
an increased ratio of men to women participants. Furthermore the number of participants
originating from Sub-Saharan countries was small, leading to a possible gap in our results
regarding their perspectives.
A strength of this study was the diversity of the study population regarding country of ori-
gin and educational level. Another strength was the different structures we visited in order to
recruit the asylum seekers for the interview, an aspect that contributed to the diversity of the
study population. Moreover, by conducting the study both in Greece and in the Netherlands,
participants were at a different stage of their journey at the time of the interview. The inter-
views in Greece were conducted at an early stage of the asylum seekers’ transnational journey
while the interviews conducted in the Netherlands represent the perspectives of asylum seekers
who are in the final stage of the asylum seeking process.
It has been proposed to implement screening and vaccination policies as a two parted
action plan, with the first part mainly taking place at arrival in the temporary hosting country
and the second part at their final recipient country [23, 24]. A similar two-step has the poten-
tial plan to resolve the gap in vaccination among adult asylum seekers. Furthermore, alteration
of screening policies in order to be in line with ECDC recommendations. Regarding STDs,
existing screening policies for infectious diseases could be expanded in order to include
screening for HIV, Hepatitis B and C. In our study, the need of vaccinations and screening
was perceived lower amongst the participants in the Netherlands. Implementation of programs
including vaccination and screening after reaching the asylum granting country may therefore
be complicated by a switch in health care priorities of the asylum seekers.
Conclusions
To conclude, participants were willing to communicate their perspectives and concerns, and
expressed a positive attitude towards vaccination and screening, understanding the rationale
behind those policies for infection prevention and protection of public health. Our findings
emphasize the need to include asylum seekers in the decision making of screening strategies.
Based on the results, point of actions could be: (i) implementation of educational outreach
programmes regarding screening, vaccination and safe sex practices, (ii) implementation of
screening and vaccination programs will likely be more successful when the asylum seekers’
need is perceived the highest, which is soon after arrival, (iii) include asylum seekers in the
decision making on screening and vaccination strategies, (iiii) potential use of an open, easy to
access online platform for communication between policy makers and asylum seekers that
could provide valuable information.
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